Bladder Cancer Targeted Drug Market: Precision Therapeutics...

ha aggiunto una foto Health

2026-07-29 10:21:35 -

Bladder Cancer Targeted Drug Market: Precision Therapeutics Transforming Uro-Oncology Outcomes

Market Overview The Bladder Cancer Targeted Drug Market is accelerating as molecular subtyping of urothelial carcinoma reveals actionable alterations in FGFR3, PI3K, and immune checkpoint pathways, shifting treatment from cytotoxic chemotherapy toward biomarker-driven precision therapy. Targeted agents—including FGFR inhibitors, antibody-drug conjugates such as enfortumab vedotin, and...

0 Commenti 0 condivisioni 4 Views 0 Anteprima